BioCentury
ARTICLE | Clinical News

WX-037: Phase I started

July 29, 2013 7:00 AM UTC

In its 6-month financial report for the period ending May 31, Wilex said it began in July an open-label, dose-escalation, U.K. Phase I trial of WX-037 alone and in combination with WX-554 in about 10...